Med Capital grows 28% in assets under management and adds new investors

Med Capital closed the past fiscal year with €344 million in assets under management, is preparing to close a real estate fund, and plans to launch a new investment vehicle.

Specializing in alternative investments focused on the real estate sector, the Barcelona-based firm is approaching €350 million in assets under management. In addition to finalizing the closure of its current fund, Med Capital is expanding its investor base and preparing a new thematic vehicle.

The firm, led by Manuel Guillén, has focused on channeling high-net-worth resources into real estate projects. Last year, it reached a record €344 million in assets under management, including both equity and debt, a 28% increase compared to 2024, including co-investments.

This increase in activity translated into a 58% rise in management fee income, reaching €3 million. Med Capital has a team of 17 professionals, half of them based in Barcelona, and also maintains offices in Madrid and Palma de Mallorca.

In Palma, the firm is developing Jardins de Nou Llevant, one of its largest projects, which involves the construction of 540 luxury homes on land acquired from Endesa in January 2025 in partnership with Meridia, led by Javier Faus. The total investment from both firms will reach €240 million. Med Capital is participating through the Med Real Estate Value 2 fund, which is expected to close soon after securing 70% of its target. The fund has €30 million in capital, complemented by up to €120 million in co-investments.

At the same time, the firm is preparing the launch of Med Real Estate Opportunity 4, a thematic fund expected to exceed €50 million, focused on development land and residential buildings in Madrid and Palma, according to the CEO.

Regarding divestments, the most significant transaction of the past year was the sale of a plot with a license to build luxury homes in Estepona (Málaga), for approximately €35 million